David G. Foster's most recent trade in Immunogen, Inc. was a trade of 342 Common Stock done at an average price of $3.9 . Disclosure was reported to the exchange on June 30, 2020.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Immunogen, Inc. | David G. Foster | V.P.-Fin., Prin. Acctg. Off. | Grant, award, or other acquisition of securities at price $ 3.91 per share. | 30 Jun 2020 | 342 | 21,724 (0%) | 0% | 3.9 | 1,337 | Common Stock |
Immunogen, Inc. | David G. Foster | V.P.-Fin., Prin. Acctg. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2020 | 18,160 | 26,830 (0%) | 0% | - | Common Stock | |
Immunogen, Inc. | David G. Foster | V.P.-Fin., Prin. Acctg. Off. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2020 | 18,160 | 27,240 | - | - | Restricted Share Unit | |
Immunogen, Inc. | David G. Foster | V.P.-Fin., Prin. Acctg. Off. | Sale of securities on an exchange or to another person at price $ 3.43 per share. | 01 Apr 2020 | 5,448 | 21,382 (0%) | 0% | 3.4 | 18,687 | Common Stock |